(Q40498315)

21 September 2017

Familial Mediterranean fever responds well to infliximab: single case experience (English)

1 reference

familial Mediterranean fever

21 September 2017

1 reference

Salih Ozgocmen

1

1 reference

21 September 2017

Levent Ozçakar

2

1 reference

21 September 2017

Ozge Ardicoglu

3

1 reference

21 September 2017

Ercan Kocakoc

4

1 reference

21 September 2017

Arzu Kaya

5

1 reference

21 September 2017

Adem Kiris

6

1 reference

21 September 2017

20 September 2005

1 reference

21 September 2017

Clinical Rheumatology

1 reference

21 September 2017

25

1 reference

21 September 2017

1

1 reference

21 September 2017

83-87

1 reference

The clinical patterns of arthritis in children with familial Mediterranean fever

21 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-005-1122-9

Induced TNF production in vitro as a test for familial Mediterranean fever

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10067-005-1122-9

Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study

21 January 2018

1 reference

12 December 2020

Unusual Immunologic Findings in Familial Mediterranean Fever

1 reference

12 December 2020

Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome.

1 reference

12 December 2020

Protracted familial Mediterranean fever arthritis

1 reference

12 December 2020

The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators.

1 reference

12 December 2020

Avascular necrosis of the femoral head foreshadowing familial Mediterranean fever: apropos of three cases

1 reference

12 December 2020

Overproduction of monocyte derived tumor necrosis factor alpha, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects.

1 reference

12 December 2020

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

1 reference

12 December 2020

Activation of the cytokine network in familial Mediterranean fever

1 reference

12 December 2020

Seronegative spondyloarthropathy in familial Mediterranean fever

1 reference

12 December 2020

Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab

1 reference

12 December 2020

Ankylosing spondylitis. An unusual manifestation of familial Mediterranean fever. Report of a case complicated by amyloidosis and polyneuropathy

1 reference

12 December 2020

The musculoskeletal manifestations of familial Mediterranean fever in children genetically diagnosed with the disease

1 reference

12 December 2020

Familial Mediterranean fever with HLA B-27 positive ankylosing spondylitis in a young Armenian man

1 reference

12 December 2020

Protracted arthritis in familial Mediterranean fever

1 reference

12 December 2020

Serum sIL-2r, IL-6, IL-10 and TNF-? level in familial Mediterranean fever patients

1 reference

12 December 2020

Arthritis in familial Mediterranean fever

1 reference

12 December 2020

Does serum rheumatoid factor have an influence on the clinical picture of ankylosing spondylitis?

1 reference

12 December 2020

Hip involvement in patients with familial Mediterranean fever. A review of ten cases

1 reference

12 December 2020

The arthritis of familial mediterranean fever

1 reference

12 December 2020

Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

1 reference

12 December 2020

Seronegative spondyloarthropathy of familial Mediterranean fever.

1 reference

12 December 2020

10.1007/S10067-005-1122-9

Identifiers

DOI

1 reference

21 September 2017

1 reference